Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Telocytes in the scalp may help with skin regeneration and maintenance.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

The serum effectively reduces hair loss and improves hair growth without side effects.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

The device helps restore sensation and grow new hair follicles after skin burns.

PRP treatment can safely improve short-term vision in acute NAION patients.

Pantethine may boost the immune system's ability to fight sarcoma.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

Nanospanlastics are effective in targeted drug delivery for chronic diseases, improving skin conditions, treating hair loss, and increasing drug absorption.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

The hydrogel helps reduce scarring and improve wound healing by releasing salvianolic acid B in acidic conditions.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.